nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafcillin—CYP3A4—prostate cancer	0.245	1	CbGaD
Nafcillin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0644	0.125	CbGbCtD
Nafcillin—CYP1A2—Flutamide—prostate cancer	0.0535	0.104	CbGbCtD
Nafcillin—SLC22A6—Conjugated Estrogens—prostate cancer	0.0497	0.0964	CbGbCtD
Nafcillin—CYP1A2—Estrone—prostate cancer	0.0387	0.0751	CbGbCtD
Nafcillin—CYP3A4—Bicalutamide—prostate cancer	0.0338	0.0657	CbGbCtD
Nafcillin—CYP3A4—Estramustine—prostate cancer	0.0315	0.061	CbGbCtD
Nafcillin—CYP3A4—Flutamide—prostate cancer	0.028	0.0544	CbGbCtD
Nafcillin—CYP3A4—Abiraterone—prostate cancer	0.028	0.0544	CbGbCtD
Nafcillin—CYP1A2—Conjugated Estrogens—prostate cancer	0.0253	0.0491	CbGbCtD
Nafcillin—CYP1A2—Estradiol—prostate cancer	0.0222	0.0431	CbGbCtD
Nafcillin—CYP3A4—Cabazitaxel—prostate cancer	0.0207	0.0402	CbGbCtD
Nafcillin—CYP3A4—Estrone—prostate cancer	0.0203	0.0393	CbGbCtD
Nafcillin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0181	0.0351	CbGbCtD
Nafcillin—CYP1A2—Etoposide—prostate cancer	0.0145	0.0282	CbGbCtD
Nafcillin—CYP3A4—Conjugated Estrogens—prostate cancer	0.0133	0.0257	CbGbCtD
Nafcillin—CYP3A4—Mitoxantrone—prostate cancer	0.0121	0.0234	CbGbCtD
Nafcillin—CYP3A4—Estradiol—prostate cancer	0.0116	0.0226	CbGbCtD
Nafcillin—CYP3A4—Prednisone—prostate cancer	0.01	0.0194	CbGbCtD
Nafcillin—CYP3A4—Etoposide—prostate cancer	0.0076	0.0148	CbGbCtD
Nafcillin—CYP3A4—Docetaxel—prostate cancer	0.00695	0.0135	CbGbCtD
Nafcillin—CYP3A4—Doxorubicin—prostate cancer	0.00518	0.0101	CbGbCtD
Nafcillin—Rash—Bicalutamide—prostate cancer	0.000229	0.00139	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Capecitabine—prostate cancer	0.000229	0.00139	CcSEcCtD
Nafcillin—Dermatitis—Bicalutamide—prostate cancer	0.000229	0.00139	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000228	0.00139	CcSEcCtD
Nafcillin—Ill-defined disorder—Estradiol—prostate cancer	0.000228	0.00139	CcSEcCtD
Nafcillin—Agranulocytosis—Etoposide—prostate cancer	0.000228	0.00138	CcSEcCtD
Nafcillin—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000227	0.00138	CcSEcCtD
Nafcillin—Angioedema—Estradiol—prostate cancer	0.000225	0.00137	CcSEcCtD
Nafcillin—Bronchospasm—Docetaxel—prostate cancer	0.000224	0.00136	CcSEcCtD
Nafcillin—Malaise—Estradiol—prostate cancer	0.000222	0.00135	CcSEcCtD
Nafcillin—Pruritus—Ethinyl Estradiol—prostate cancer	0.000218	0.00132	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000217	0.00132	CcSEcCtD
Nafcillin—Pain—Goserelin—prostate cancer	0.000217	0.00132	CcSEcCtD
Nafcillin—Bronchospasm—Capecitabine—prostate cancer	0.000217	0.00132	CcSEcCtD
Nafcillin—Nausea—Bicalutamide—prostate cancer	0.000216	0.00131	CcSEcCtD
Nafcillin—Skin exfoliation—Doxorubicin—prostate cancer	0.000216	0.00131	CcSEcCtD
Nafcillin—Pancytopenia—Docetaxel—prostate cancer	0.000216	0.00131	CcSEcCtD
Nafcillin—Pain—Conjugated Estrogens—prostate cancer	0.000214	0.0013	CcSEcCtD
Nafcillin—Ill-defined disorder—Mitoxantrone—prostate cancer	0.000213	0.00129	CcSEcCtD
Nafcillin—Neutropenia—Docetaxel—prostate cancer	0.000213	0.00129	CcSEcCtD
Nafcillin—Abdominal discomfort—Capecitabine—prostate cancer	0.000211	0.00128	CcSEcCtD
Nafcillin—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00021	0.00128	CcSEcCtD
Nafcillin—Arthralgia—Estradiol—prostate cancer	0.000209	0.00127	CcSEcCtD
Nafcillin—Myalgia—Estradiol—prostate cancer	0.000209	0.00127	CcSEcCtD
Nafcillin—Pancytopenia—Capecitabine—prostate cancer	0.000209	0.00127	CcSEcCtD
Nafcillin—Feeling abnormal—Goserelin—prostate cancer	0.000209	0.00127	CcSEcCtD
Nafcillin—Gastrointestinal pain—Goserelin—prostate cancer	0.000207	0.00126	CcSEcCtD
Nafcillin—Discomfort—Estradiol—prostate cancer	0.000207	0.00126	CcSEcCtD
Nafcillin—Malaise—Mitoxantrone—prostate cancer	0.000207	0.00126	CcSEcCtD
Nafcillin—Phlebitis—Epirubicin—prostate cancer	0.000206	0.00125	CcSEcCtD
Nafcillin—Neutropenia—Capecitabine—prostate cancer	0.000206	0.00125	CcSEcCtD
Nafcillin—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000205	0.00125	CcSEcCtD
Nafcillin—Thrombophlebitis—Epirubicin—prostate cancer	0.000205	0.00125	CcSEcCtD
Nafcillin—Urticaria—Goserelin—prostate cancer	0.000201	0.00122	CcSEcCtD
Nafcillin—Anaphylactic shock—Estradiol—prostate cancer	0.000201	0.00122	CcSEcCtD
Nafcillin—Abdominal pain—Goserelin—prostate cancer	0.0002	0.00122	CcSEcCtD
Nafcillin—Body temperature increased—Goserelin—prostate cancer	0.0002	0.00122	CcSEcCtD
Nafcillin—Renal failure—Docetaxel—prostate cancer	0.000199	0.00121	CcSEcCtD
Nafcillin—Urticaria—Conjugated Estrogens—prostate cancer	0.000199	0.00121	CcSEcCtD
Nafcillin—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000198	0.0012	CcSEcCtD
Nafcillin—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000198	0.0012	CcSEcCtD
Nafcillin—Stomatitis—Docetaxel—prostate cancer	0.000198	0.0012	CcSEcCtD
Nafcillin—Shock—Estradiol—prostate cancer	0.000197	0.0012	CcSEcCtD
Nafcillin—Vomiting—Ethinyl Estradiol—prostate cancer	0.000196	0.00119	CcSEcCtD
Nafcillin—Arthralgia—Mitoxantrone—prostate cancer	0.000195	0.00119	CcSEcCtD
Nafcillin—Myalgia—Mitoxantrone—prostate cancer	0.000195	0.00119	CcSEcCtD
Nafcillin—Rash—Ethinyl Estradiol—prostate cancer	0.000194	0.00118	CcSEcCtD
Nafcillin—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000194	0.00118	CcSEcCtD
Nafcillin—Renal failure—Capecitabine—prostate cancer	0.000193	0.00117	CcSEcCtD
Nafcillin—Discomfort—Mitoxantrone—prostate cancer	0.000193	0.00117	CcSEcCtD
Nafcillin—Stomatitis—Capecitabine—prostate cancer	0.000191	0.00116	CcSEcCtD
Nafcillin—Phlebitis—Doxorubicin—prostate cancer	0.000191	0.00116	CcSEcCtD
Nafcillin—Thrombophlebitis—Doxorubicin—prostate cancer	0.00019	0.00115	CcSEcCtD
Nafcillin—Agranulocytosis—Docetaxel—prostate cancer	0.000189	0.00115	CcSEcCtD
Nafcillin—Haematuria—Capecitabine—prostate cancer	0.000187	0.00114	CcSEcCtD
Nafcillin—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000187	0.00114	CcSEcCtD
Nafcillin—Hypersensitivity—Goserelin—prostate cancer	0.000187	0.00113	CcSEcCtD
Nafcillin—Renal impairment—Epirubicin—prostate cancer	0.000186	0.00113	CcSEcCtD
Nafcillin—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000185	0.00112	CcSEcCtD
Nafcillin—Shock—Mitoxantrone—prostate cancer	0.000184	0.00112	CcSEcCtD
Nafcillin—Neutropenia—Prednisone—prostate cancer	0.000183	0.00111	CcSEcCtD
Nafcillin—Agranulocytosis—Capecitabine—prostate cancer	0.000183	0.00111	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000183	0.00111	CcSEcCtD
Nafcillin—Nausea—Ethinyl Estradiol—prostate cancer	0.000183	0.00111	CcSEcCtD
Nafcillin—Pruritus—Goserelin—prostate cancer	0.000179	0.00109	CcSEcCtD
Nafcillin—Pruritus—Conjugated Estrogens—prostate cancer	0.000177	0.00108	CcSEcCtD
Nafcillin—Ill-defined disorder—Etoposide—prostate cancer	0.000177	0.00107	CcSEcCtD
Nafcillin—Hypotension—Mitoxantrone—prostate cancer	0.000175	0.00106	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Estradiol—prostate cancer	0.000173	0.00105	CcSEcCtD
Nafcillin—Diarrhoea—Goserelin—prostate cancer	0.000173	0.00105	CcSEcCtD
Nafcillin—Renal impairment—Doxorubicin—prostate cancer	0.000172	0.00105	CcSEcCtD
Nafcillin—Malaise—Etoposide—prostate cancer	0.000172	0.00104	CcSEcCtD
Nafcillin—Pain—Estradiol—prostate cancer	0.000172	0.00104	CcSEcCtD
Nafcillin—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000172	0.00104	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.00017	0.00104	CcSEcCtD
Nafcillin—Feeling abnormal—Estradiol—prostate cancer	0.000165	0.00101	CcSEcCtD
Nafcillin—Gastrointestinal pain—Estradiol—prostate cancer	0.000164	0.000997	CcSEcCtD
Nafcillin—Liver function test abnormal—Epirubicin—prostate cancer	0.000164	0.000995	CcSEcCtD
Nafcillin—Vomiting—Goserelin—prostate cancer	0.000161	0.000978	CcSEcCtD
Nafcillin—Discomfort—Etoposide—prostate cancer	0.00016	0.000974	CcSEcCtD
Nafcillin—Pain—Mitoxantrone—prostate cancer	0.00016	0.000972	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Epirubicin—prostate cancer	0.00016	0.000971	CcSEcCtD
Nafcillin—Rash—Goserelin—prostate cancer	0.00016	0.00097	CcSEcCtD
Nafcillin—Dermatitis—Goserelin—prostate cancer	0.000159	0.000969	CcSEcCtD
Nafcillin—Vomiting—Conjugated Estrogens—prostate cancer	0.000159	0.000969	CcSEcCtD
Nafcillin—Urticaria—Estradiol—prostate cancer	0.000159	0.000969	CcSEcCtD
Nafcillin—Abdominal pain—Estradiol—prostate cancer	0.000159	0.000964	CcSEcCtD
Nafcillin—Body temperature increased—Estradiol—prostate cancer	0.000159	0.000964	CcSEcCtD
Nafcillin—Rash—Conjugated Estrogens—prostate cancer	0.000158	0.000961	CcSEcCtD
Nafcillin—Dermatitis—Conjugated Estrogens—prostate cancer	0.000158	0.00096	CcSEcCtD
Nafcillin—Anaphylactic shock—Etoposide—prostate cancer	0.000156	0.000945	CcSEcCtD
Nafcillin—Feeling abnormal—Mitoxantrone—prostate cancer	0.000154	0.000937	CcSEcCtD
Nafcillin—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000153	0.000929	CcSEcCtD
Nafcillin—Eosinophilia—Epirubicin—prostate cancer	0.000152	0.000923	CcSEcCtD
Nafcillin—Liver function test abnormal—Doxorubicin—prostate cancer	0.000152	0.000921	CcSEcCtD
Nafcillin—Nausea—Goserelin—prostate cancer	0.00015	0.000914	CcSEcCtD
Nafcillin—Nausea—Conjugated Estrogens—prostate cancer	0.000149	0.000905	CcSEcCtD
Nafcillin—Urticaria—Mitoxantrone—prostate cancer	0.000149	0.000903	CcSEcCtD
Nafcillin—Hypersensitivity—Estradiol—prostate cancer	0.000148	0.000899	CcSEcCtD
Nafcillin—Body temperature increased—Mitoxantrone—prostate cancer	0.000148	0.000898	CcSEcCtD
Nafcillin—Abdominal pain—Mitoxantrone—prostate cancer	0.000148	0.000898	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000148	0.000898	CcSEcCtD
Nafcillin—Pancytopenia—Epirubicin—prostate cancer	0.000146	0.000885	CcSEcCtD
Nafcillin—Hypotension—Etoposide—prostate cancer	0.000145	0.000883	CcSEcCtD
Nafcillin—Neutropenia—Epirubicin—prostate cancer	0.000143	0.000871	CcSEcCtD
Nafcillin—Ill-defined disorder—Capecitabine—prostate cancer	0.000142	0.000865	CcSEcCtD
Nafcillin—Pruritus—Estradiol—prostate cancer	0.000142	0.000863	CcSEcCtD
Nafcillin—Eosinophilia—Doxorubicin—prostate cancer	0.00014	0.000854	CcSEcCtD
Nafcillin—Malaise—Capecitabine—prostate cancer	0.000138	0.000841	CcSEcCtD
Nafcillin—Hypersensitivity—Mitoxantrone—prostate cancer	0.000138	0.000837	CcSEcCtD
Nafcillin—Diarrhoea—Estradiol—prostate cancer	0.000137	0.000835	CcSEcCtD
Nafcillin—Arthralgia—Docetaxel—prostate cancer	0.000135	0.00082	CcSEcCtD
Nafcillin—Myalgia—Docetaxel—prostate cancer	0.000135	0.00082	CcSEcCtD
Nafcillin—Pancytopenia—Doxorubicin—prostate cancer	0.000135	0.000819	CcSEcCtD
Nafcillin—Renal failure—Epirubicin—prostate cancer	0.000134	0.000817	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Etoposide—prostate cancer	0.000134	0.000816	CcSEcCtD
Nafcillin—Stomatitis—Epirubicin—prostate cancer	0.000133	0.00081	CcSEcCtD
Nafcillin—Pain—Etoposide—prostate cancer	0.000133	0.000808	CcSEcCtD
Nafcillin—Neutropenia—Doxorubicin—prostate cancer	0.000133	0.000806	CcSEcCtD
Nafcillin—Myalgia—Capecitabine—prostate cancer	0.000131	0.000794	CcSEcCtD
Nafcillin—Arthralgia—Capecitabine—prostate cancer	0.000131	0.000794	CcSEcCtD
Nafcillin—Haematuria—Epirubicin—prostate cancer	0.00013	0.000792	CcSEcCtD
Nafcillin—Anaphylactic shock—Docetaxel—prostate cancer	0.000129	0.000786	CcSEcCtD
Nafcillin—Discomfort—Capecitabine—prostate cancer	0.000129	0.000784	CcSEcCtD
Nafcillin—Feeling abnormal—Etoposide—prostate cancer	0.000128	0.000779	CcSEcCtD
Nafcillin—Diarrhoea—Mitoxantrone—prostate cancer	0.000128	0.000778	CcSEcCtD
Nafcillin—Vomiting—Estradiol—prostate cancer	0.000128	0.000776	CcSEcCtD
Nafcillin—Agranulocytosis—Epirubicin—prostate cancer	0.000128	0.000775	CcSEcCtD
Nafcillin—Gastrointestinal pain—Etoposide—prostate cancer	0.000127	0.000773	CcSEcCtD
Nafcillin—Shock—Docetaxel—prostate cancer	0.000127	0.000773	CcSEcCtD
Nafcillin—Ill-defined disorder—Prednisone—prostate cancer	0.000127	0.00077	CcSEcCtD
Nafcillin—Rash—Estradiol—prostate cancer	0.000127	0.000769	CcSEcCtD
Nafcillin—Dermatitis—Estradiol—prostate cancer	0.000126	0.000768	CcSEcCtD
Nafcillin—Angioedema—Prednisone—prostate cancer	0.000125	0.000759	CcSEcCtD
Nafcillin—Renal failure—Doxorubicin—prostate cancer	0.000124	0.000756	CcSEcCtD
Nafcillin—Urticaria—Etoposide—prostate cancer	0.000124	0.000751	CcSEcCtD
Nafcillin—Stomatitis—Doxorubicin—prostate cancer	0.000123	0.000749	CcSEcCtD
Nafcillin—Malaise—Prednisone—prostate cancer	0.000123	0.000749	CcSEcCtD
Nafcillin—Shock—Capecitabine—prostate cancer	0.000123	0.000748	CcSEcCtD
Nafcillin—Body temperature increased—Etoposide—prostate cancer	0.000123	0.000747	CcSEcCtD
Nafcillin—Abdominal pain—Etoposide—prostate cancer	0.000123	0.000747	CcSEcCtD
Nafcillin—Hypotension—Docetaxel—prostate cancer	0.000121	0.000734	CcSEcCtD
Nafcillin—Haematuria—Doxorubicin—prostate cancer	0.000121	0.000733	CcSEcCtD
Nafcillin—Nausea—Estradiol—prostate cancer	0.000119	0.000725	CcSEcCtD
Nafcillin—Vomiting—Mitoxantrone—prostate cancer	0.000119	0.000723	CcSEcCtD
Nafcillin—Agranulocytosis—Doxorubicin—prostate cancer	0.000118	0.000717	CcSEcCtD
Nafcillin—Rash—Mitoxantrone—prostate cancer	0.000118	0.000717	CcSEcCtD
Nafcillin—Dermatitis—Mitoxantrone—prostate cancer	0.000118	0.000716	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000118	0.000716	CcSEcCtD
Nafcillin—Hypotension—Capecitabine—prostate cancer	0.000117	0.000711	CcSEcCtD
Nafcillin—Arthralgia—Prednisone—prostate cancer	0.000116	0.000707	CcSEcCtD
Nafcillin—Myalgia—Prednisone—prostate cancer	0.000116	0.000707	CcSEcCtD
Nafcillin—Discomfort—Prednisone—prostate cancer	0.000115	0.000698	CcSEcCtD
Nafcillin—Hypersensitivity—Etoposide—prostate cancer	0.000115	0.000697	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000114	0.000693	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000112	0.000678	CcSEcCtD
Nafcillin—Anaphylactic shock—Prednisone—prostate cancer	0.000111	0.000678	CcSEcCtD
Nafcillin—Nausea—Mitoxantrone—prostate cancer	0.000111	0.000675	CcSEcCtD
Nafcillin—Pain—Docetaxel—prostate cancer	0.000111	0.000672	CcSEcCtD
Nafcillin—Pruritus—Etoposide—prostate cancer	0.00011	0.000669	CcSEcCtD
Nafcillin—Shock—Prednisone—prostate cancer	0.00011	0.000667	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000108	0.000657	CcSEcCtD
Nafcillin—Pain—Capecitabine—prostate cancer	0.000107	0.00065	CcSEcCtD
Nafcillin—Feeling abnormal—Docetaxel—prostate cancer	0.000107	0.000647	CcSEcCtD
Nafcillin—Diarrhoea—Etoposide—prostate cancer	0.000106	0.000647	CcSEcCtD
Nafcillin—Gastrointestinal pain—Docetaxel—prostate cancer	0.000106	0.000642	CcSEcCtD
Nafcillin—Feeling abnormal—Capecitabine—prostate cancer	0.000103	0.000627	CcSEcCtD
Nafcillin—Gastrointestinal pain—Capecitabine—prostate cancer	0.000102	0.000622	CcSEcCtD
Nafcillin—Abdominal pain—Docetaxel—prostate cancer	0.000102	0.000621	CcSEcCtD
Nafcillin—Body temperature increased—Docetaxel—prostate cancer	0.000102	0.000621	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000102	0.000617	CcSEcCtD
Nafcillin—Urticaria—Capecitabine—prostate cancer	9.94e-05	0.000604	CcSEcCtD
Nafcillin—Ill-defined disorder—Epirubicin—prostate cancer	9.91e-05	0.000602	CcSEcCtD
Nafcillin—Body temperature increased—Capecitabine—prostate cancer	9.89e-05	0.000601	CcSEcCtD
Nafcillin—Abdominal pain—Capecitabine—prostate cancer	9.89e-05	0.000601	CcSEcCtD
Nafcillin—Vomiting—Etoposide—prostate cancer	9.89e-05	0.000601	CcSEcCtD
Nafcillin—Rash—Etoposide—prostate cancer	9.81e-05	0.000596	CcSEcCtD
Nafcillin—Dermatitis—Etoposide—prostate cancer	9.8e-05	0.000596	CcSEcCtD
Nafcillin—Malaise—Epirubicin—prostate cancer	9.64e-05	0.000586	CcSEcCtD
Nafcillin—Hypersensitivity—Docetaxel—prostate cancer	9.52e-05	0.000579	CcSEcCtD
Nafcillin—Nausea—Etoposide—prostate cancer	9.24e-05	0.000562	CcSEcCtD
Nafcillin—Hypersensitivity—Capecitabine—prostate cancer	9.22e-05	0.00056	CcSEcCtD
Nafcillin—Feeling abnormal—Prednisone—prostate cancer	9.19e-05	0.000558	CcSEcCtD
Nafcillin—Ill-defined disorder—Doxorubicin—prostate cancer	9.17e-05	0.000557	CcSEcCtD
Nafcillin—Pruritus—Docetaxel—prostate cancer	9.15e-05	0.000556	CcSEcCtD
Nafcillin—Gastrointestinal pain—Prednisone—prostate cancer	9.12e-05	0.000554	CcSEcCtD
Nafcillin—Arthralgia—Epirubicin—prostate cancer	9.1e-05	0.000553	CcSEcCtD
Nafcillin—Myalgia—Epirubicin—prostate cancer	9.1e-05	0.000553	CcSEcCtD
Nafcillin—Discomfort—Epirubicin—prostate cancer	8.99e-05	0.000546	CcSEcCtD
Nafcillin—Malaise—Doxorubicin—prostate cancer	8.92e-05	0.000542	CcSEcCtD
Nafcillin—Urticaria—Prednisone—prostate cancer	8.86e-05	0.000538	CcSEcCtD
Nafcillin—Pruritus—Capecitabine—prostate cancer	8.86e-05	0.000538	CcSEcCtD
Nafcillin—Diarrhoea—Docetaxel—prostate cancer	8.85e-05	0.000538	CcSEcCtD
Nafcillin—Abdominal pain—Prednisone—prostate cancer	8.81e-05	0.000536	CcSEcCtD
Nafcillin—Body temperature increased—Prednisone—prostate cancer	8.81e-05	0.000536	CcSEcCtD
Nafcillin—Anaphylactic shock—Epirubicin—prostate cancer	8.72e-05	0.00053	CcSEcCtD
Nafcillin—Shock—Epirubicin—prostate cancer	8.58e-05	0.000521	CcSEcCtD
Nafcillin—Diarrhoea—Capecitabine—prostate cancer	8.56e-05	0.00052	CcSEcCtD
Nafcillin—Arthralgia—Doxorubicin—prostate cancer	8.42e-05	0.000511	CcSEcCtD
Nafcillin—Myalgia—Doxorubicin—prostate cancer	8.42e-05	0.000511	CcSEcCtD
Nafcillin—Discomfort—Doxorubicin—prostate cancer	8.32e-05	0.000505	CcSEcCtD
Nafcillin—Vomiting—Docetaxel—prostate cancer	8.22e-05	0.0005	CcSEcCtD
Nafcillin—Hypersensitivity—Prednisone—prostate cancer	8.21e-05	0.000499	CcSEcCtD
Nafcillin—Rash—Docetaxel—prostate cancer	8.15e-05	0.000495	CcSEcCtD
Nafcillin—Hypotension—Epirubicin—prostate cancer	8.15e-05	0.000495	CcSEcCtD
Nafcillin—Dermatitis—Docetaxel—prostate cancer	8.14e-05	0.000495	CcSEcCtD
Nafcillin—Anaphylactic shock—Doxorubicin—prostate cancer	8.07e-05	0.00049	CcSEcCtD
Nafcillin—Vomiting—Capecitabine—prostate cancer	7.96e-05	0.000484	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Epirubicin—prostate cancer	7.94e-05	0.000483	CcSEcCtD
Nafcillin—Shock—Doxorubicin—prostate cancer	7.94e-05	0.000482	CcSEcCtD
Nafcillin—Rash—Capecitabine—prostate cancer	7.89e-05	0.00048	CcSEcCtD
Nafcillin—Pruritus—Prednisone—prostate cancer	7.89e-05	0.000479	CcSEcCtD
Nafcillin—Dermatitis—Capecitabine—prostate cancer	7.88e-05	0.000479	CcSEcCtD
Nafcillin—Nausea—Docetaxel—prostate cancer	7.68e-05	0.000467	CcSEcCtD
Nafcillin—Diarrhoea—Prednisone—prostate cancer	7.63e-05	0.000464	CcSEcCtD
Nafcillin—Hypotension—Doxorubicin—prostate cancer	7.54e-05	0.000458	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Epirubicin—prostate cancer	7.53e-05	0.000458	CcSEcCtD
Nafcillin—Pain—Epirubicin—prostate cancer	7.46e-05	0.000453	CcSEcCtD
Nafcillin—Nausea—Capecitabine—prostate cancer	7.43e-05	0.000452	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.35e-05	0.000447	CcSEcCtD
Nafcillin—Feeling abnormal—Epirubicin—prostate cancer	7.19e-05	0.000437	CcSEcCtD
Nafcillin—Gastrointestinal pain—Epirubicin—prostate cancer	7.13e-05	0.000433	CcSEcCtD
Nafcillin—Vomiting—Prednisone—prostate cancer	7.09e-05	0.000431	CcSEcCtD
Nafcillin—Rash—Prednisone—prostate cancer	7.03e-05	0.000427	CcSEcCtD
Nafcillin—Dermatitis—Prednisone—prostate cancer	7.02e-05	0.000427	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.97e-05	0.000423	CcSEcCtD
Nafcillin—Urticaria—Epirubicin—prostate cancer	6.93e-05	0.000421	CcSEcCtD
Nafcillin—Pain—Doxorubicin—prostate cancer	6.9e-05	0.000419	CcSEcCtD
Nafcillin—Body temperature increased—Epirubicin—prostate cancer	6.89e-05	0.000419	CcSEcCtD
Nafcillin—Abdominal pain—Epirubicin—prostate cancer	6.89e-05	0.000419	CcSEcCtD
Nafcillin—Feeling abnormal—Doxorubicin—prostate cancer	6.65e-05	0.000404	CcSEcCtD
Nafcillin—Nausea—Prednisone—prostate cancer	6.62e-05	0.000402	CcSEcCtD
Nafcillin—Gastrointestinal pain—Doxorubicin—prostate cancer	6.6e-05	0.000401	CcSEcCtD
Nafcillin—Hypersensitivity—Epirubicin—prostate cancer	6.42e-05	0.00039	CcSEcCtD
Nafcillin—Urticaria—Doxorubicin—prostate cancer	6.41e-05	0.00039	CcSEcCtD
Nafcillin—Body temperature increased—Doxorubicin—prostate cancer	6.38e-05	0.000388	CcSEcCtD
Nafcillin—Abdominal pain—Doxorubicin—prostate cancer	6.38e-05	0.000388	CcSEcCtD
Nafcillin—Pruritus—Epirubicin—prostate cancer	6.17e-05	0.000375	CcSEcCtD
Nafcillin—Diarrhoea—Epirubicin—prostate cancer	5.97e-05	0.000363	CcSEcCtD
Nafcillin—Hypersensitivity—Doxorubicin—prostate cancer	5.94e-05	0.000361	CcSEcCtD
Nafcillin—Pruritus—Doxorubicin—prostate cancer	5.71e-05	0.000347	CcSEcCtD
Nafcillin—Vomiting—Epirubicin—prostate cancer	5.54e-05	0.000337	CcSEcCtD
Nafcillin—Diarrhoea—Doxorubicin—prostate cancer	5.52e-05	0.000335	CcSEcCtD
Nafcillin—Rash—Epirubicin—prostate cancer	5.5e-05	0.000334	CcSEcCtD
Nafcillin—Dermatitis—Epirubicin—prostate cancer	5.49e-05	0.000334	CcSEcCtD
Nafcillin—Nausea—Epirubicin—prostate cancer	5.18e-05	0.000315	CcSEcCtD
Nafcillin—Vomiting—Doxorubicin—prostate cancer	5.13e-05	0.000312	CcSEcCtD
Nafcillin—Rash—Doxorubicin—prostate cancer	5.09e-05	0.000309	CcSEcCtD
Nafcillin—Dermatitis—Doxorubicin—prostate cancer	5.08e-05	0.000309	CcSEcCtD
Nafcillin—Nausea—Doxorubicin—prostate cancer	4.79e-05	0.000291	CcSEcCtD
Nafcillin—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	2.87e-05	0.00038	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	2.83e-05	0.000375	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.77e-05	0.000367	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	2.76e-05	0.000365	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	2.75e-05	0.000365	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—COMT—prostate cancer	2.67e-05	0.000354	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.65e-05	0.000352	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	2.64e-05	0.00035	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.63e-05	0.000349	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.62e-05	0.000347	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	2.54e-05	0.000337	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	2.46e-05	0.000326	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.44e-05	0.000323	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GRHL1—prostate cancer	2.41e-05	0.00032	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PSAT1—prostate cancer	2.41e-05	0.00032	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TST—prostate cancer	2.41e-05	0.00032	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CSAD—prostate cancer	2.41e-05	0.00032	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CBR1—prostate cancer	2.41e-05	0.00032	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ADI1—prostate cancer	2.41e-05	0.00032	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.41e-05	0.000319	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	2.36e-05	0.000312	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.31e-05	0.000307	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	2.31e-05	0.000306	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HAO1—prostate cancer	2.28e-05	0.000303	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.28e-05	0.000302	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—UGT2B15—prostate cancer	2.24e-05	0.000297	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CKMT2—prostate cancer	2.24e-05	0.000297	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GRHPR—prostate cancer	2.24e-05	0.000297	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—UGT2B17—prostate cancer	2.24e-05	0.000297	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	2.19e-05	0.00029	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.19e-05	0.00029	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	2.16e-05	0.000286	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NAGLU—prostate cancer	2.11e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—MBTPS1—prostate cancer	2.11e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AOX1—prostate cancer	2.11e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTM3—prostate cancer	2.11e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—RFK—prostate cancer	2.11e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SULT2B1—prostate cancer	2.11e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PGAM2—prostate cancer	2.11e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	2.06e-05	0.000273	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AMACR—prostate cancer	2e-05	0.000265	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP3A43—prostate cancer	2e-05	0.000265	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NAT1—prostate cancer	2e-05	0.000265	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SRD5A2—prostate cancer	2e-05	0.000265	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—DEGS1—prostate cancer	2e-05	0.000265	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.96e-05	0.00026	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.95e-05	0.000259	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HSD17B1—prostate cancer	1.91e-05	0.000253	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.91e-05	0.000253	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ADI1—prostate cancer	1.86e-05	0.000247	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CBR1—prostate cancer	1.86e-05	0.000247	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GRHL1—prostate cancer	1.86e-05	0.000247	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PSAT1—prostate cancer	1.86e-05	0.000247	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TST—prostate cancer	1.86e-05	0.000247	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CSAD—prostate cancer	1.86e-05	0.000247	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.83e-05	0.000243	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.82e-05	0.000242	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.8e-05	0.000239	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GRHPR—prostate cancer	1.73e-05	0.000229	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.73e-05	0.000229	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.73e-05	0.000229	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CKMT2—prostate cancer	1.73e-05	0.000229	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.72e-05	0.000228	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—B4GALT4—prostate cancer	1.7e-05	0.000225	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HPGD—prostate cancer	1.7e-05	0.000225	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NAGLU—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—RFK—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PGAM2—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTM3—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AOX1—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TNFRSF21—prostate cancer	1.6e-05	0.000212	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—MTAP—prostate cancer	1.55e-05	0.000206	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP7B1—prostate cancer	1.55e-05	0.000206	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AMACR—prostate cancer	1.54e-05	0.000204	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.54e-05	0.000204	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.54e-05	0.000204	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—DEGS1—prostate cancer	1.54e-05	0.000204	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NAT1—prostate cancer	1.54e-05	0.000204	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.52e-05	0.000201	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SULT1E1—prostate cancer	1.51e-05	0.000201	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SRD5A1—prostate cancer	1.51e-05	0.000201	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.47e-05	0.000195	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.47e-05	0.000195	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.45e-05	0.000192	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HSD17B3—prostate cancer	1.44e-05	0.000191	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ACSL4—prostate cancer	1.44e-05	0.000191	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.43e-05	0.000189	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ARG2—prostate cancer	1.38e-05	0.000184	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—UMPS—prostate cancer	1.38e-05	0.000184	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PHGDH—prostate cancer	1.38e-05	0.000184	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.38e-05	0.000183	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—LDHB—prostate cancer	1.36e-05	0.00018	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP3A5—prostate cancer	1.33e-05	0.000177	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HPGD—prostate cancer	1.31e-05	0.000174	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.31e-05	0.000174	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PDHA1—prostate cancer	1.29e-05	0.000171	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—UCP3—prostate cancer	1.29e-05	0.000171	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TCN2—prostate cancer	1.29e-05	0.000171	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA3—prostate cancer	1.29e-05	0.000171	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.23e-05	0.000163	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SLC22A3—prostate cancer	1.23e-05	0.000163	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HSD3B1—prostate cancer	1.23e-05	0.000163	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—MTAP—prostate cancer	1.2e-05	0.000159	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.2e-05	0.000159	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.19e-05	0.000158	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TBXAS1—prostate cancer	1.18e-05	0.000156	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA4—prostate cancer	1.18e-05	0.000156	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.17e-05	0.000155	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.17e-05	0.000155	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.15e-05	0.000153	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA2—prostate cancer	1.15e-05	0.000152	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SULT1A1—prostate cancer	1.13e-05	0.00015	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ABCG5—prostate cancer	1.13e-05	0.00015	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ACSL4—prostate cancer	1.11e-05	0.000148	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.11e-05	0.000148	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA1—prostate cancer	1.11e-05	0.000147	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTO1—prostate cancer	1.09e-05	0.000145	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NAT2—prostate cancer	1.09e-05	0.000145	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HSD3B2—prostate cancer	1.09e-05	0.000145	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—UMPS—prostate cancer	1.07e-05	0.000142	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PHGDH—prostate cancer	1.07e-05	0.000142	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ARG2—prostate cancer	1.07e-05	0.000142	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.05e-05	0.00014	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PLCB2—prostate cancer	1.05e-05	0.000139	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP2C18—prostate cancer	1.05e-05	0.000139	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—LRP2—prostate cancer	1.05e-05	0.000139	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—LDHB—prostate cancer	1.05e-05	0.000139	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—P4HB—prostate cancer	1.03e-05	0.000136	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.03e-05	0.000136	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SLC22A1—prostate cancer	1e-05	0.000133	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PDHA1—prostate cancer	9.93e-06	0.000132	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA3—prostate cancer	9.93e-06	0.000132	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—UCP3—prostate cancer	9.93e-06	0.000132	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TCN2—prostate cancer	9.93e-06	0.000132	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	9.89e-06	0.000131	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SULT2A1—prostate cancer	9.76e-06	0.000129	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—MED12—prostate cancer	9.6e-06	0.000127	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GNG5—prostate cancer	9.52e-06	0.000126	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HSD3B1—prostate cancer	9.48e-06	0.000126	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SLC22A3—prostate cancer	9.48e-06	0.000126	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NCOA3—prostate cancer	9.17e-06	0.000122	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA4—prostate cancer	9.09e-06	0.00012	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TBXAS1—prostate cancer	9.09e-06	0.00012	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	9.01e-06	0.000119	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA2—prostate cancer	8.85e-06	0.000117	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HPGDS—prostate cancer	8.75e-06	0.000116	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.75e-06	0.000116	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ABCG5—prostate cancer	8.75e-06	0.000116	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP2C19—prostate cancer	8.7e-06	0.000115	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA1—prostate cancer	8.54e-06	0.000113	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTT1—prostate cancer	8.49e-06	0.000112	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ACHE—prostate cancer	8.49e-06	0.000112	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HSD3B2—prostate cancer	8.45e-06	0.000112	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTO1—prostate cancer	8.45e-06	0.000112	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NAT2—prostate cancer	8.45e-06	0.000112	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP2A6—prostate cancer	8.39e-06	0.000111	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	8.36e-06	0.000111	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AKR1C3—prostate cancer	8.16e-06	0.000108	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PRKACB—prostate cancer	8.12e-06	0.000108	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PLCB2—prostate cancer	8.1e-06	0.000107	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—LRP2—prostate cancer	8.1e-06	0.000107	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP2C18—prostate cancer	8.1e-06	0.000107	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP17A1—prostate cancer	8.03e-06	0.000106	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—P4HB—prostate cancer	7.94e-06	0.000105	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.92e-06	0.000105	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.73e-06	0.000102	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NCOA2—prostate cancer	7.66e-06	0.000101	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.53e-06	9.98e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—MED12—prostate cancer	7.41e-06	9.82e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GNG5—prostate cancer	7.35e-06	9.74e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SLC5A5—prostate cancer	7.3e-06	9.68e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP2E1—prostate cancer	7.13e-06	9.45e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NCOA3—prostate cancer	7.08e-06	9.38e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NQO1—prostate cancer	7.05e-06	9.35e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TH—prostate cancer	6.95e-06	9.21e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.91e-06	9.15e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP3A4—prostate cancer	6.88e-06	9.12e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.84e-06	9.07e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP1B1—prostate cancer	6.76e-06	8.96e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HPGDS—prostate cancer	6.75e-06	8.95e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.71e-06	8.89e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ACHE—prostate cancer	6.55e-06	8.68e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTT1—prostate cancer	6.55e-06	8.68e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GGT1—prostate cancer	6.55e-06	8.68e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.47e-06	8.58e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NCOA1—prostate cancer	6.45e-06	8.55e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP19A1—prostate cancer	6.36e-06	8.43e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.3e-06	8.35e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PRKACB—prostate cancer	6.26e-06	8.3e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.2e-06	8.22e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—RXRA—prostate cancer	6.14e-06	8.13e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.97e-06	7.91e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—COMT—prostate cancer	5.91e-06	7.83e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NCOA2—prostate cancer	5.91e-06	7.83e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTP1—prostate cancer	5.88e-06	7.8e-05	CbGpPWpGaD
Nafcillin—Flucloxacillin—CYP3A4—prostate cancer	5.86e-06	0.42	CrCbGaD
Nafcillin—CYP1A2—Metabolism—ITPR1—prostate cancer	5.79e-06	7.67e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.69e-06	7.54e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.64e-06	7.47e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.5e-06	7.3e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TYMS—prostate cancer	5.47e-06	7.25e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NQO1—prostate cancer	5.44e-06	7.22e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTM1—prostate cancer	5.41e-06	7.17e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TH—prostate cancer	5.36e-06	7.11e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—LPL—prostate cancer	5.31e-06	7.03e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.22e-06	6.92e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP1A1—prostate cancer	5.12e-06	6.79e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ERCC2—prostate cancer	5.08e-06	6.74e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GGT1—prostate cancer	5.05e-06	6.7e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NCOA1—prostate cancer	4.98e-06	6.6e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.91e-06	6.5e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—MTHFR—prostate cancer	4.78e-06	6.33e-05	CbGpPWpGaD
Nafcillin—Amoxicillin—CYP2C19—prostate cancer	4.74e-06	0.34	CrCbGaD
Nafcillin—CYP3A4—Metabolism—RXRA—prostate cancer	4.74e-06	6.28e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PPARA—prostate cancer	4.69e-06	6.21e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—COMT—prostate cancer	4.56e-06	6.05e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTP1—prostate cancer	4.54e-06	6.02e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ITPR1—prostate cancer	4.47e-06	5.92e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CAV1—prostate cancer	4.41e-06	5.84e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TYMS—prostate cancer	4.22e-06	5.59e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.21e-06	5.58e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTM1—prostate cancer	4.17e-06	5.53e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—LPL—prostate cancer	4.1e-06	5.43e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CG—prostate cancer	4.01e-06	5.32e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.95e-06	5.24e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ERCC2—prostate cancer	3.92e-06	5.2e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—INS—prostate cancer	3.8e-06	5.04e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CREBBP—prostate cancer	3.72e-06	4.93e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—MTHFR—prostate cancer	3.69e-06	4.89e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PPARA—prostate cancer	3.62e-06	4.79e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CD—prostate cancer	3.53e-06	4.68e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CAV1—prostate cancer	3.4e-06	4.51e-05	CbGpPWpGaD
Nafcillin—Dicloxacillin—CYP3A4—prostate cancer	3.37e-06	0.241	CrCbGaD
Nafcillin—CYP1A2—Metabolism—NOS3—prostate cancer	3.33e-06	4.42e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.1e-06	4.11e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CB—prostate cancer	3.08e-06	4.08e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PTGS2—prostate cancer	3.05e-06	4.04e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—INS—prostate cancer	2.93e-06	3.89e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CREBBP—prostate cancer	2.87e-06	3.81e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.72e-06	3.61e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PTEN—prostate cancer	2.66e-06	3.52e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NOS3—prostate cancer	2.57e-06	3.41e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—EP300—prostate cancer	2.53e-06	3.36e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.37e-06	3.15e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PTGS2—prostate cancer	2.35e-06	3.12e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PTEN—prostate cancer	2.05e-06	2.72e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—EP300—prostate cancer	1.96e-06	2.59e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.87e-06	2.49e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AKT1—prostate cancer	1.53e-06	2.03e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.45e-06	1.92e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AKT1—prostate cancer	1.18e-06	1.57e-05	CbGpPWpGaD
